XBIOTECH INC. Increase (Decrease) in Income Taxes Payable
XBIOTECH INC. (XBIT) reported Increase (Decrease) in Income Taxes Payable of -$41.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-13
- XBIOTECH INC. increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was -$90.00K, a 421.43% decline year-over-year.
- XBIOTECH INC. increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $49.00K, a 68.97% increase year-over-year.
- XBIOTECH INC. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was -$81.00K.
- XBIOTECH INC. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was $102.00K.
- XBIOTECH INC. increase (decrease) in income taxes payable for fiscal 2025 was $78.00K.
- XBIOTECH INC. increase (decrease) in income taxes payable for fiscal 2024 was -$24.00K, a 119.51% decline from fiscal 2023.
- XBIOTECH INC. increase (decrease) in income taxes payable for fiscal 2023 was $123.00K, a 20.65% decline from fiscal 2022.
- XBIOTECH INC. increase (decrease) in income taxes payable for fiscal 2022 was $155.00K, a 26.89% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 9 month as first filed | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$41.00K 10-Q · filed 2026-08-13 | -$122.00K derived: sum of 3 quarters · filed 2026-08-13 | -$20.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-14 | -$32.00K derived: sum of 2 quarters · filed 2026-05-14 | $70.00K derived: sum of 3 quarters · filed 2026-05-14 | $98.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $21.00K derived: sum of 2 quarters · filed 2026-03-13 | $49.00K derived: sum of 3 quarters · filed 2026-08-13 | $78.00K 10-K · filed 2026-03-13 | |
| 2025-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $130.00K derived: sum of 2 quarters · filed 2026-08-13 | $159.00K 10-Q · filed 2025-11-12 | $143.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $57.00K 10-Q · filed 2026-08-13 | $41.00K derived: sum of 3 quarters · filed 2026-08-13 | -$18.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $29.00K 10-Q · filed 2026-05-14 | $13.00K derived: sum of 2 quarters · filed 2026-05-14 | -$46.00K derived: sum of 3 quarters · filed 2026-05-14 | -$20.00K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$75.00K derived: sum of 2 quarters · filed 2026-03-13 | -$49.00K derived: sum of 3 quarters · filed 2026-03-13 | -$24.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$33.00K derived: sum of 2 quarters · filed 2025-11-12 | -$8.00K 10-Q · filed 2025-11-12 | -$59.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $51.00K 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $182.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $25.00K 10-Q · filed 2025-05-14 | -$26.00K derived: sum of 2 quarters · filed 2025-05-14 | $156.00K derived: sum of 3 quarters · filed 2025-05-14 | $126.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $131.00K derived: sum of 2 quarters · filed 2025-03-18 | $101.00K derived: sum of 3 quarters · filed 2025-03-18 | $123.00K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $152.00K derived: sum of 2 quarters · filed 2024-11-13 | $174.00K 10-Q · filed 2024-11-13 | $15.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$8.00K 10-Q · filed 2024-08-12 | -$167.00K derived: sum of 3 quarters · filed 2024-08-12 | -$129.00K derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $22.00K 10-Q · filed 2024-05-10 | -$137.00K derived: sum of 2 quarters · filed 2024-05-10 | -$99.00K derived: sum of 3 quarters · filed 2024-05-10 | $173.00K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$121.00K derived: sum of 2 quarters · filed 2024-03-15 | $151.00K derived: sum of 3 quarters · filed 2024-03-15 | $155.00K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $310.00K derived: sum of 2 quarters · filed 2023-11-09 | $314.00K 10-Q · filed 2023-11-09 | -$808.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $276.00K 10-Q · filed 2023-08-11 | -$846.00K derived: sum of 3 quarters · filed 2023-08-11 | -$360.00K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-10 | -$1.12M derived: sum of 2 quarters · filed 2023-05-10 | -$632.00K derived: sum of 3 quarters · filed 2023-05-10 | $216.00K derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$636.00K derived: sum of 2 quarters · filed 2023-03-15 | $212.00K derived: sum of 3 quarters · filed 2023-03-15 | $212.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $486.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.33M derived: sum of 2 quarters · filed 2022-11-09 | $1.33M 10-Q · filed 2022-11-09 | $1.40M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $848.00K 10-Q · filed 2022-08-10 | $913.00K derived: sum of 3 quarters · filed 2022-08-10 | $47.71M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $65.00K derived: sum of 2 quarters · filed 2022-05-10 | $46.86M derived: sum of 3 quarters · filed 2022-05-10 | $47.70M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $46.86M derived: sum of 2 quarters · filed 2022-03-15 | $47.70M derived: sum of 3 quarters · filed 2022-03-15 | $65.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $46.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $47.64M derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | -$49.34M 10-Q · filed 2020-11-09 | $1.06M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $844.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$46.80M 10-Q · filed 2021-08-09 | -$45.74M derived: sum of 3 quarters · filed 2022-03-15 | -$45.74M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | -$47.64M 10-Q · filed 2021-05-10 | -$46.58M derived: sum of 2 quarters · filed 2022-03-15 | -$46.58M derived: sum of 3 quarters · filed 2022-03-15 | ||
| 2019-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.06M derived: sum of 2 quarters · filed 2022-03-15 | $1.06M 10-K · filed 2022-03-15 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |